Moolec Science
MLEC

$0.8210

4.53%

Market Cap: $30.8M

About: Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system.

Employees: 45

0

Funds holding %

of 6,728 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

230% more capital invested

Capital invested by funds: $48.6K [Q1] → $160K (+$112K) [Q2]

80% more funds holding

Funds holding: 5 [Q1] → 9 (+4) [Q2]

0.3% more ownership

Funds ownership: 0.09% [Q1] → 0.39% (+0.3%) [Q2]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for MLEC.

See Analyst Rankings

Financial journalist opinion

Moolec Received NASDAQ Bid Price Letter

LUXEMBOURG / ACCESSWIRE / September 13, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today that it received a letter (the "Nasdaq Bid Price Letter") from Nasdaq notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company's ordinary shares has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The Nasdaq Bid Price Letter has no immediate effect on the listing of the Company's common stock, and its common stock will continue to trade on The Nasdaq Capital Market under the symbol "MLEC".

Moolec Received NASDAQ Bid Price Letter

Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October

LUXEMBOURG / ACCESSWIRE / September 5, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASO™ and Piggy Sooy™ during October 2024. GLASO™ and Piggy Sooy™ US Harvest Announcement GLASO™ (gamma-linolenic acid -GLA- in safflower oil) campaign located in Idaho consists of 600 planted acres of genetically modified safflower, mainly for commercial purposes.

Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October

Top 4 Risk Off Stocks You'll Regret Missing In July

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. `

Top 4 Risk Off Stocks You'll Regret Missing In July

Why Is Moolec Science (MLEC) Stock Down 18% Today?

Moolec Science (NASDAQ: MLEC ) stock is falling on Monday even as the molecular farming ingredient company announced an offtake agreement with a global consumer packaged goods company. According to a press release from Moolec Science, this covers the use of its GLA Safflower Oil (GLASO) product.

Why Is Moolec Science (MLEC) Stock Down 18% Today?

Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025

LUXEMBOURG / ACCESSWIRE / July 15, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a Molecular Farming ingredient company, announced today the signing of an offtake agreement with one of the largest global consumer packaged goods and pet food companies for the use of Moolec's patented science-based GLA Safflower Oil product, GLASO™ (the "Agreement"). This initial offtake agreement has a term of three years and establishes commercial conditions for the delivery of GLASO™ in US territory with an initial estimated volume of 50 tons for 2025.

Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025

Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript

Moolec Science SA (NASDAQ:MLEC ) Q3 2024 Earnings Conference Call May 30, 2024 8:30 AM ET Company Participants Gaston Paladini - CEO and Co-Founder Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO Bruce William - Plant Scientist Conference Call Participants Thomas McGovern - Maxim Group Scott Fortune - Roth MKM Bruce William This morning, you will hear from Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec Science, together with Jose Lopez Lecube, Chief Financial Officer and Amit Dhingra, Chief Science Officer. In today's call, we will be referring to a presentation that is available on the company's Investor Relations website.

Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript

Moolec Announces New Patent Granting in the United States for Molecular Farming Platform

LUXEMBOURG / ACCESSWIRE / April 30, 2024 / Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a Molecular Farming food-ingredient company, announced today the granting of a patent family in the United States for its SPC2 product produced in safflower with Molecular Farming technology. This new patent adjudication will give the company, through its U.S. sole-owned subsidiary AG Biomolecules LLC, exclusivity for the use of the technology until 2041.

Moolec Announces New Patent Granting in the United States for Molecular Farming Platform

Why Is Moolec Science (MLEC) Stock Up 121% Today?

Moolec Science (NASDAQ: MLEC ) stock is taking off on Monday after the company got approval from the Food and Drug Administration (FDA) for its plant-grown animal proteins. According to a press release from the company, this covers its genetically engineered soybean that accumulates animal proteins.

Why Is Moolec Science (MLEC) Stock Up 121% Today?

Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins

LUXEMBOURG / ACCESSWIRE / April 22, 2024 / Moolec Science SA (NASDAQ:MLEC)("The company"), a Molecular Farming food-ingredient company, announced today that the Animal and Plant Health Inspection Service ("APHIS") of the U.S. Department of Agriculture ("USDA") has concluded its Regulatory Status Review ("RSR") for Moolec's genetically engineered ("GE") soybean Piggy Sooy™. See post online here: https://www.aphis.usda.gov/sites/default/files/23-234-01rsr-response.pdf [1].

Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins

Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update

LUXEMBOURG / ACCESSWIRE / March 13, 2024 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023. Moolec Logo Moolec Science Logo The main highlights of Moolec's business update are as follows: SOOY1 | Piggy Sooy™ Platform: Third generation (T3) soybean seed propagation has started, and fourth generation (T4) seeds are expected to be harvested in April 2024.

Moolec Science Presents Second Quarter Fiscal Year 2024 Business Update

See News Rankings